Our Pricing

Buy Mounjaro & Wegovy Online UK: Expert Guide to GLP-1 Weight Loss Injections

Published on: June 03, 2026

When you buy Mounjaro and Wegovy online UK through Cured Pharmacy, you're accessing the latest GLP-1 receptor agonist treatments with full clinical oversight from UK-registered prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) leads a team committed to transparent pricing, genuine UK-licensed medicines, and discreet home delivery—all following a free online consultation that takes under three minutes.

How Mounjaro and Wegovy Work for Weight Loss

Mounjaro (tirzepatide) represents a significant advancement as the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

Wegovy (semaglutide) works through selective GLP-1 receptor activation, mimicking the natural hormone that regulates appetite and food intake [2]. In the STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks, whilst SURPASS-2 showed tirzepatide produced up to 22.5% weight reduction at the highest dose [1][2]. Both medications slow gastric emptying and increase feelings of fullness, helping patients reduce caloric intake naturally.

These injectable treatments require once-weekly administration and are prescribed only after a UK clinician assesses your medical history, current medications, and weight management goals. At Cured Pharmacy, Mounjaro starts from £124.99 and Wegovy from £135.00, with all prices shown upfront before your consultation begins.

Mounjaro vs Wegovy: Clinical Efficacy and Patient Suitability

Head-to-head comparisons show tirzepatide generally produces greater weight reduction than semaglutide, though both medications demonstrate robust clinical efficacy [3]. The SURPASS-2 trial directly compared these agents in patients with type 2 diabetes, revealing tirzepatide 15mg achieved superior glycaemic control and weight loss compared to semaglutide 1mg [3].

Patient suitability depends on multiple factors including BMI, comorbidities, previous weight loss attempts, and tolerance of gastrointestinal side effects. Wegovy may be preferred for patients new to GLP-1 therapy due to its established safety profile and lower starting cost, whilst Mounjaro offers an option for those seeking maximum efficacy or who have not achieved goals with semaglutide-based treatments.

Who Can Access These Treatments?

NICE guidelines recommend GLP-1 receptor agonists for adults with a BMI of 35 kg/m² or above (or 32.5 kg/m² for certain ethnic groups), or a BMI of 30 kg/m² with weight-related comorbidities such as hypertension or type 2 diabetes [4]. Your UK prescriber will evaluate your eligibility during the online consultation, reviewing contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease.

What to Expect During Your Online Consultation

Cured Pharmacy's online consultation takes under three minutes and covers essential medical history, current medications, allergies, and weight management objectives. Our UK-registered prescribers assess whether Mounjaro, Wegovy, or alternative treatments align with your clinical profile and safety requirements.

If approved, your prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in discreet packaging with next-day delivery options available. Each pen arrives with full patient information leaflets, injection technique guidance, and access to our clinical team for ongoing support throughout your treatment journey.

Transparent Pricing Before You Start

Unlike many online services, Cured Pharmacy displays exact pricing before your consultation begins. You'll see the cost of your prescribed dose upfront—no hidden fees, no surprise charges at checkout. We guarantee the lowest prices in the UK for genuine, MHRA-licensed weight loss injections, and our pricing remains competitive with high-street pharmacies whilst offering the convenience of home delivery.

Dosing Schedules and Treatment Titration

Both Mounjaro and Wegovy follow gradual dose escalation schedules to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Mounjaro typically begins at 2.5mg weekly for four weeks, increasing every four weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum maintenance dose of 15mg [1]. Wegovy starts at 0.25mg weekly, escalating monthly to 0.5mg, 1mg, 1.7mg, and finally 2.4mg maintenance dose [2].

Your prescriber determines the appropriate titration schedule based on your tolerance and response. Some patients achieve their weight loss goals at intermediate doses and may not require maximum dosing. Regular follow-up consultations—available through Cured Pharmacy's online platform—ensure your treatment remains safe and effective throughout the programme.

Managing Side Effects and Optimising Results

The most common side effects of GLP-1 receptor agonists include nausea, diarrhoea, constipation, vomiting, and abdominal discomfort, typically occurring during dose escalation phases [1][2]. These effects usually diminish within several weeks as your body adapts to the medication. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise gastrointestinal symptoms.

Serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other diabetes medications). Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction. Our clinical team at Cured Pharmacy remains available to address concerns and adjust your treatment plan as needed.

Combining Medication with Lifestyle Changes

Clinical trials demonstrating significant weight loss with tirzepatide and semaglutide included lifestyle intervention programmes comprising reduced-calorie diets and increased physical activity [1][2]. Whilst these medications powerfully reduce appetite and facilitate caloric restriction, optimal outcomes occur when combined with sustainable dietary modifications and regular exercise. Your prescriber may recommend nutritional counselling or refer you to weight management support services to maximise long-term success.

Alternative Weight Loss Treatments Available at Cured Pharmacy

For patients unsuitable for injectable GLP-1 therapies or seeking different treatment modalities, Cured Pharmacy offers several alternatives. Saxenda (liraglutide) provides daily injection therapy with established efficacy, whilst Orlistat and Xenical work through fat absorption inhibition rather than appetite suppression. These oral medications may suit patients with needle aversion or those preferring non-hormonal approaches.

Wegovy oral tablets (semaglutide pill) represent an emerging option for patients seeking GLP-1 benefits without injections, currently available for pre-order through our platform. Your UK prescriber will discuss all suitable options during your consultation, considering your preferences, medical history, and treatment goals to identify the most appropriate weight management strategy.

Why Choose Cured Pharmacy for Weight Loss Treatment

As a fully GPhC-registered online pharmacy (9012511), Cured Pharmacy combines regulatory compliance with patient-centred service. Our superintendent pharmacist Tarun Kumar ensures every prescription meets MHRA standards, whilst our UK clinical team provides personalised care without the time constraints of traditional GP appointments. We guarantee 100% discreet packaging, genuine UK-licensed medicines, and transparent pricing that's consistently lower than high-street alternatives—with the added convenience of home delivery and ongoing clinical support throughout your weight loss journey.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.